These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29269255)

  • 1. Immunoproteasome inhibition and bioactivity of thiasyrbactins.
    Bakas NA; Schultz CR; Yco LP; Roberts CC; Chang CA; Bachmann AS; Pirrung MC
    Bioorg Med Chem; 2018 Jan; 26(2):401-412. PubMed ID: 29269255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of 2-thioxoimidazolidin-4-one derivatives as novel noncovalent proteasome and immunoproteasome inhibitors.
    Maccari R; Ettari R; Adornato I; Naß A; Wolber G; Bitto A; Mannino F; Aliquò F; Bruno G; Nicolò F; Previti S; Grasso S; Zappalà M; Ottanà R
    Bioorg Med Chem Lett; 2018 Feb; 28(3):278-283. PubMed ID: 29292224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity enhancement of the synthetic syrbactin proteasome inhibitor hybrid and biological evaluation in tumor cells.
    Archer CR; Groll M; Stein ML; Schellenberg B; Clerc J; Kaiser M; Kondratyuk TP; Pezzuto JM; Dudler R; Bachmann AS
    Biochemistry; 2012 Aug; 51(34):6880-8. PubMed ID: 22870914
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blockade of the malignant phenotype by β-subunit selective noncovalent inhibition of immuno- and constitutive proteasomes.
    Villoutreix BO; Khatib AM; Cheng Y; Miteva MA; Maréchal X; Vidal J; Reboud-Ravaux M
    Oncotarget; 2017 Feb; 8(6):10437-10449. PubMed ID: 28060729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis and bioactivity of fused- and spiro-β-lactone-lactam systems.
    Josa-Culleré L; Towers C; Willenbrock F; Macaulay VM; Christensen KE; Moloney MG
    Org Biomol Chem; 2017 Jun; 15(25):5373-5379. PubMed ID: 28617490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thiasyrbactins Induce Cell Death
    Pierce MR; Bakas NA; Pirrung MC; Bachmann AS
    Anticancer Res; 2018 Oct; 38(10):5607-5613. PubMed ID: 30275178
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structure-based design of human immuno- and constitutive proteasomes inhibitors.
    Richy N; Sarraf D; Maréchal X; Janmamode N; Le Guével R; Genin E; Reboud-Ravaux M; Vidal J
    Eur J Med Chem; 2018 Feb; 145():570-587. PubMed ID: 29339252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enzyme inhibition by hydroamination: design and mechanism of a hybrid carmaphycin-syringolin enone proteasome inhibitor.
    Trivella DB; Pereira AR; Stein ML; Kasai Y; Byrum T; Valeriote FA; Tantillo DJ; Groll M; Gerwick WH; Moore BS
    Chem Biol; 2014 Jun; 21(6):782-91. PubMed ID: 24930969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of isoquinolinone derivatives as immunoproteasome inhibitors.
    Ettari R; Iraci N; Di Chio C; Previti S; Danzè M; Zappalà M
    Bioorg Med Chem Lett; 2022 Jan; 55():128478. PubMed ID: 34838650
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-covalent immunoproteasome inhibitors induce cell cycle arrest in multiple myeloma MM.1R cells.
    Ettari R; Pallio G; Pizzino G; Irrera N; Zappalà M; Maiorana S; Di Chio C; Altavilla D; Squadrito F; Bitto A
    J Enzyme Inhib Med Chem; 2019 Dec; 34(1):1307-1313. PubMed ID: 31307247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Development of novel proteasome inhibitors based on phthalazinone scaffold.
    Yang L; Wang W; Sun Q; Xu F; Niu Y; Wang C; Liang L; Xu P
    Bioorg Med Chem Lett; 2016 Jun; 26(12):2801-2805. PubMed ID: 27158142
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonpeptidic Selective Inhibitors of the Chymotrypsin-Like (β5 i) Subunit of the Immunoproteasome.
    Sosič I; Gobec M; Brus B; Knez D; Živec M; Konc J; Lešnik S; Ogrizek M; Obreza A; Žigon D; Janežič D; Mlinarič-Raščan I; Gobec S
    Angew Chem Int Ed Engl; 2016 May; 55(19):5745-8. PubMed ID: 27037901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure-based design of β1i or β5i specific inhibitors of human immunoproteasomes.
    de Bruin G; Huber EM; Xin BT; van Rooden EJ; Al-Ayed K; Kim KB; Kisselev AF; Driessen C; van der Stelt M; van der Marel GA; Groll M; Overkleeft HS
    J Med Chem; 2014 Jul; 57(14):6197-209. PubMed ID: 25006746
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New 26S proteasome inhibitors with high selectivity for chymotrypsin-like activity and p53-dependent cytotoxicity.
    Neilsen PM; Pehere AD; Pishas KI; Callen DF; Abell AD
    ACS Chem Biol; 2013 Feb; 8(2):353-9. PubMed ID: 23190346
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development of peptide epoxyketones as selective immunoproteasome inhibitors.
    Li X; Hong D; Zhang M; Xu L; Zhou Y; Li J; Liu T
    Eur J Med Chem; 2021 Oct; 221():113556. PubMed ID: 34087498
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selective immunoproteasome inhibitors with non-peptide scaffolds identified from structure-based virtual screening.
    Kasam V; Lee NR; Kim KB; Zhan CG
    Bioorg Med Chem Lett; 2014 Aug; 24(15):3614-7. PubMed ID: 24913713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of two direct C(sp3)-H functionalizations for total synthesis of (+)-lactacystin.
    Yoshioka S; Nagatomo M; Inoue M
    Org Lett; 2015 Jan; 17(1):90-3. PubMed ID: 25526222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tetradehydrohalicyclamine B, a new proteasome inhibitor from the marine sponge Acanthostrongylophora ingens.
    Kato H; El-Desoky AH; Takeishi Y; Nehira T; Angkouw ED; Mangindaan REP; de Voogd NJ; Tsukamoto S
    Bioorg Med Chem Lett; 2019 Jan; 29(1):8-10. PubMed ID: 30455150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Potent and Highly Selective Inhibitors of the Proteasome Trypsin-like Site by Incorporation of Basic Side Chain Containing Amino Acid Derived Sulfonyl Fluorides.
    Artschwager R; Ward DJ; Gannon S; Brouwer AJ; van de Langemheen H; Kowalski H; Liskamp RMJ
    J Med Chem; 2018 Jun; 61(12):5395-5411. PubMed ID: 29782167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synthesis and biological properties of C-terminal vinyl ketone pseudotripeptides.
    Franceschini C; Trapella C; Sforza F; Gavioli R; Marastoni M
    J Enzyme Inhib Med Chem; 2013 Jun; 28(3):560-4. PubMed ID: 22380778
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.